Answers are grounded in this paper and cite their sources.
New anticancer therapies have improved patient outcomes but associated dermatologic adverse events (AEs) may cause morbidity and treatment discontinuation. A comprehensive estimation of associations between cancer drugs and skin AEs is lacking.
No takes yet. Share an insight, caveat, or question.
Salah et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: